All SARS-CoV-2 / COVID-19 at the Institut Pasteur

An epidemic of pneumonia of viral appearance and of unknown etiology emerged in the city of Wuhan (Hubei province, China) in December 2019. On January 9, 2020, the discovery of a new coronavirus (first called 2019-nCoV, then SARS-CoV-2) was officially announced by the Chinese health authorities and the World Health Organization (WHO). This coronavirus is the agent responsible for the new infectious respiratory disease called Covid-19 (CoronaVIrus Disease 2019).


The Institut Pasteur (Paris) and the Institut Pasteur International Network have been extremely active worldwide in responding with science to the pandemic caused by the SARS-CoV-2 coronavirus, responsible for Covid-19 disease.


Here are the news, press releases and videos from the Institut Pasteur (Paris), which was mobilized as soon as the first cases were announced, following the declaration of the epidemic by the Chinese authorities.

COVID-19 : un projet vaccin lentiviral par voie intra-nasale assure une protection importante chez l’animal
Scientists from the Institut Pasteur-TheraVectys Joint Laboratory recently published in Cell Host & Microbe1 the results of tests, in two preclinical models, of a COVID-19 vaccine candidate using a lentiviral vector administered by nasal route. Their study demonstrates that the vaccine candidate induces antibody response with strong neutralizing activity against SARS-CoV-2, as well as substantial cell-mediated responses.
Throughout the world, long-term care facilities have been high-risk sites for virus spread since the emergence of the COVID-19 epidemic. In this context, the capacity for timely surveillance and control of case numbers is essential in such facilities. Scientists at the Institut Pasteur have joined forces with the University of Versailles-Saint-Quentin-en-Yvelines, Inserm, and the National Conservatory of Arts and Trades to analyze various methods for surveillance and testing of residents at these facilities.
INNOVATION - Our Sucess Stories - Institut Pasteur
The Institut Pasteur International Network, with the support of the International Department of the Institut Pasteur (Paris) and in association with institutional funders, has mobilised to help certain member institutes in Africa and Asia to carry out their public health missions in the context of the management of the COVID-19 pandemic.  The objective of this aid was to provide them with financial and logistical support to strengthen their surveillance, diagnosis and response systems in the face of the virus.


Covid-19 disease fact sheet (novel coronavirus)

Fiche Maladie Covid-19 - Institut Pasteur

All the information about Covid-19 disease, caused by the SARS-CoV-2 coronavirus (cause, symptoms, transmission, prevention, treatment, etc.). The Covid-19 fact sheet is updated regularly.




Coronavirus : attention aux fausses informations circulant sur les réseaux sociaux - Institut Pasteur

Coronavirus SARS-CoV-2 and Covid-19: beware of false information


Back to top